|
Mar. 08, 2021 |
|
|
Mar. 03, 2025 |
|
|
jRCTs031200402 |
Search for abnormalities of fundus blood vessels in moyamoya disease |
|
Search for abnormalities of fundus blood vessels in moyamoya disease |
|
July. 10, 2023 |
|
17 |
|
The mean age (standard deviation) was 46.7 (11.9) years, with 4 males and 13 females |
|
The pace of enrollment was slower and less frequent than originally anticipated: 17 patients with Moyamoya disease were enrolled, 17 of whom underwent fundus fluorescence angiography, and one of whom was terminated due to nausea as an adverse reaction during the examination. |
|
One patient developed nausea and wheals as an allergic reaction to indocyanine green contrast medium, so subsequent fluorescein fluoroscopy was discontinued. |
|
Of the 16 patients who underwent fluorescence angiography, 2 were excluded from the analysis because of a history of obvious retinal vascular lesions. Fourteen patients were included in the analysis, of which 4 (28.6%) had abnormal retinal vascular structures..Abnormalities of retinal vascular structure included capillary dilatation, loop-like structures of peripheral vessels, and arteriovenous and venous shunts. |
|
Of the patients with moyamoya disease, 4/14 (28.6%) had abnormal retinal vasculature. Abnormal retinal vasculature included capillary dilatation, looping of peripheral vessels, and arteriovenous and venous shunts.Moyamoya disease can cause changes in retinal vasculature. |
|
Jan. 31, 2025 |
No |
|
NO |
|
https://jrct.mhlw.go.jp/latest-detail/jRCTs031200402 |
Akiyama Hideo |
||
Gunma University Hospital |
||
3-39-15, Showa-machi, Maebashi-shi, Gunma |
||
+81-27-220-8338 |
||
akiyamah47@gunma-u.ac.jp |
||
Akiyama Hideo |
||
Gunma University Hospital |
||
3-39-15, Showa-machi, Maebashi-shi, Gunma |
||
+81-27-220-8338 |
||
akiyamah47@gunma-u.ac.jp |
Complete |
Mar. 08, 2021 |
||
| April. 23, 2021 | ||
| 50 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
no treatment control/standard of care control |
||
single assignment |
||
screening |
||
Moyamoya disease patient group |
||
Moyamoya disease patient group |
||
| 20age old over | ||
| No limit | ||
Both |
||
Moyamoya disease |
||
For fluorescein fundus angiography, 500 mg of fluorescein (5 ml vial of aqueous solution containing 500 mg of fluorescein) and 25 mg of Ophthagreen (2 ml of blue indocyanine green) are dissolved in 2 ml of distilled water for injection and injected through the forearm of the elbow vein. In daily practice, diabetic retinopathy can be treated by using a diabetic retinal imaging system (optos). In daily practice, it is used for the diagnosis of diabetic retinopathy, uveitis, occlusive retinal vascular disease, and age-related macular degeneration. |
||
Moyamoya disease |
||
058 |
||
Prevalence of Retinal Vasculature Abnormalities in Patients with Moyamoya Disease on Fluorescence Fundus Angiography |
||
Retinal blood vessel density, area of central fovea no-reflux area, subcentral foveal retinal thickness, and subcentral foveal choroidal thickness obtained from retinal optical coherence tomography and retinal optical coherence angiography will be compared between groups of patients with moyamoya disease and normal fundus. |
||
| Eisai Co., Ltd | |
| Not applicable |
| Gunma University Hospital Clinical Research Review Board | |
| 3-39-15, Showa-cho, Maebashi City, Gunma | |
+81-27-220-8740 |
|
| irb-jimukk-ciru@ml.gunma-u.ac.jp | |
| Approval | |
Mar. 01, 2021 |
none |